NIH-funded research R01 grant

Activatexto: help Latinos quit smoking and get more activity

Official title: Actívatexto: Advancing smoking cessation and physical activity among Latinos

Funded at University of Rochester · NIH-11382025 · Data updated 2026-11-12

A Latino-focused program uses text messages to help adults quit smoking and become more physically active.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startSeptember 20, 2024
Project endMay 31, 2029
Funding year2026
Award (this year)$2,214,880
NIH project number4R01MD019748-03
Project IDNIH-11382025 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21+ who smoke and are not meeting activity guidelines, particularly within Latino communities.

Less likely to help

Individuals who do not use mobile texting or are not interested in behavior-change programs may have limited benefit.

What this research studies

This project builds on a successful text-message smoking-cessation program for Latinos and adds a physical activity component to boost quitting and overall health. It will enroll adults 21 and older, especially Cuban and Latino communities, and deliver tailored messages through mobile phones in English and Spanish. The study will work with a Community Advisory Board to ensure the program fits real-life needs and preferences, with a focus on real-world use and potential for broad adoption. If effective, the intervention could become a scalable tool to reduce smoking and increase activity in Latino communities.

Why it matters

Potential benefit: If successful, the program could help more Latino adults quit smoking and increase their weekly physical activity, improving health and reducing disease risk.

How similar studies have gone: A prior randomized trial showed Decídetexto increases smoking abstinence among Latinos, supporting further integration with activity components.

Where this research is happening

  • University of Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Cartujano, Francisco — University of Rochester
  • Study coordinator: Cartujano, Francisco

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.